mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.0003 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0004 |